Apollo Endosurgery ROA 2006-2018 | APEN
Current and historical return on assets (ROA) values for Apollo Endosurgery (APEN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Apollo Endosurgery ROA for the three months ending September 30, 2018 was -33.12%.
| Apollo Endosurgery ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2018-09-30 | $-0.04B | $0.10B | -33.33% |
| 2018-06-30 | $-0.03B | $0.11B | -27.65% |
| 2018-03-31 | $-0.03B | $0.10B | -26.34% |
| 2017-12-31 | $-0.03B | $0.11B | -27.14% |
| 2017-09-30 | $-0.03B | $0.11B | -33.76% |
| 2017-06-30 | $-0.04B | $0.09B | -51.25% |
| 2017-03-31 | $-0.04B | $0.09B | -81.19% |
| 2016-12-31 | $-0.04B | $0.10B | -133.33% |
| 2016-09-30 | $-0.06B | $0.00B | -180.95% |
| 2016-06-30 | $-0.05B | $0.01B | -150.00% |
| 2016-03-31 | $-0.04B | $0.01B | -116.67% |
| 2015-12-31 | $-0.04B | $0.11B | -98.01% |
| 2015-09-30 | $-0.01B | $0.01B | -83.58% |
| 2015-06-30 | $-0.02B | $0.02B | -75.00% |
| 2015-03-31 | $-0.02B | $0.02B | -77.11% |
| 2014-12-31 | $-0.02B | $0.02B | -72.73% |
| 2014-09-30 | $-0.01B | $0.03B | -53.01% |
| 2014-06-30 | $-0.01B | $0.02B | -59.46% |
| 2014-03-31 | $-0.01B | $0.02B | -42.11% |
| 2013-12-31 | $-0.01B | $0.02B | -31.17% |
| 2013-09-30 | $-0.01B | $0.02B | -31.82% |
| 2013-06-30 | $-0.01B | $0.02B | -22.47% |
| 2013-03-31 | $-0.01B | $0.02B | -22.22% |
| 2012-12-31 | $-0.00B | $0.03B | -13.33% |
| 2012-09-30 | $-0.01B | $0.02B | -24.69% |
| 2012-06-30 | $-0.00B | $0.02B | -14.63% |
| 2012-03-31 | $-0.00B | $0.02B | -6.56% |
| 2011-12-31 | $-0.00B | $0.02B | -42.11% |
| 2011-09-30 | $0.00B | $0.02B | 0.00% |
| 2011-06-30 | $-0.00B | $0.00B | -66.67% |
| 2011-03-31 | $-0.01B | $0.00B | -100.00% |
| 2010-12-31 | $-0.00B | $0.02B | -50.00% |
| 2010-09-30 | $-0.00B | $0.00B | inf% |
| 2010-06-30 | $0.01B | $0.00B | 350.00% |
| 2010-03-31 | $0.00B | $0.00B | 106.67% |
| 2009-12-31 | $0.00B | $0.00B | 69.57% |
| 2009-09-30 | $0.00B | $0.01B | 25.00% |
| 2009-06-30 | $-0.01B | $0.01B | -90.32% |
| 2009-03-31 | $-0.01B | $0.01B | -74.07% |
| 2008-12-31 | $-0.01B | $0.01B | -169.23% |
| 2008-09-30 | $-0.01B | $0.01B | -200.00% |
| 2008-06-30 | $-0.02B | $0.00B | -206.45% |
| 2008-03-31 | $-0.02B | $0.01B | -167.44% |
| 2007-12-31 | $-0.02B | $0.01B | -168.42% |
| 2007-09-30 | $-0.01B | $0.01B | -180.65% |
| 2007-06-30 | $-0.01B | $0.02B | -173.91% |
| 2007-03-31 | $-0.01B | $0.00B | -215.38% |
| 2006-12-31 | $-0.01B | $0.00B | -117.65% |
| 2006-09-30 | $-0.01B | $0.00B | -114.29% |
| 2006-06-30 | $-0.01B | $0.01B | -117.65% |
| 2006-03-31 | $-0.00B | $0.01B | -133.33% |
| 2005-12-31 | $-0.00B | $0.01B | -200.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.071B | $0.064B |
| Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $94.457B | 22.01 |
| Intuitive Surgical (ISRG) | United States | $58.919B | 57.97 |
| Edwards Lifesciences (EW) | United States | $32.745B | 35.04 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $21.185B | 14.32 |
| IDEXX Laboratories (IDXX) | United States | $17.009B | 48.58 |
| ABIOMED (ABMD) | United States | $14.599B | 104.90 |
| DexCom (DXCM) | United States | $13.065B | 0.00 |
| Hologic (HOLX) | United States | $12.427B | 19.18 |
| Teleflex (TFX) | United States | $11.433B | 25.95 |
| Varian Medical Systems (VAR) | United States | $11.421B | 28.42 |
| STERIS (STE) | United Kingdom | $9.401B | 24.94 |
| Masimo (MASI) | United States | $6.157B | 39.92 |
| Penumbra (PEN) | United States | $4.736B | 285.98 |
| LivaNova (LIVN) | United Kingdom | $4.387B | 28.16 |
| Globus Medical (GMED) | United States | $4.190B | 26.26 |
| Integra LifeSciences Holdings (IART) | United States | $3.928B | 19.13 |
| Wright Medical Group (WMGI) | Netherlands | $3.581B | 0.00 |
| Cantel Medical (CMD) | United States | $3.276B | 32.31 |
| Inogen (INGN) | United States | $3.121B | 67.36 |
| Integer Holdings (ITGR) | United States | $2.609B | 21.83 |
| Tandem Diabetes Care (TNDM) | United States | $2.522B | 0.00 |
| Glaukos (GKOS) | United States | $2.123B | 0.00 |
| Halyard Health (AVNS) | United States | $2.108B | 18.99 |
| OPKO Health (OPK) | United States | $2.088B | 0.00 |
| Nevro (NVRO) | United States | $1.261B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.134B | 180.50 |
| Luminex (LMNX) | United States | $1.133B | 41.00 |
| Natus Medical (BABY) | United States | $1.121B | 23.56 |
| Pacific Biosciences Of California (PACB) | United States | $1.083B | 0.00 |
| CryoLife (CRY) | United States | $1.054B | 91.93 |
| Orthofix (OFIX) | United States | $0.964B | 27.83 |
| Intersect ENT (XENT) | United States | $0.873B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.867B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.832B | 49.20 |
| AngioDynamics (ANGO) | United States | $0.772B | 25.05 |
| ViewRay (VRAY) | United States | $0.716B | 0.00 |
| Veracyte (VCYT) | United States | $0.646B | 0.00 |
| TransEnterix (TRXC) | United States | $0.590B | 0.00 |
| AxoGen (AXGN) | United States | $0.560B | 0.00 |
| Si-Bone (SIBN) | United States | $0.538B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.411B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.409B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.396B | 0.00 |
| Sientra (SIEN) | United States | $0.381B | 0.00 |
| Fluidigm (FLDM) | United States | $0.340B | 0.00 |
| Accuray (ARAY) | United States | $0.336B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.335B | 0.00 |
| IRadimed (IRMD) | United States | $0.287B | 74.97 |
| SeaSpine Holdings (SPNE) | United States | $0.278B | 0.00 |
| Neuronetics (STIM) | United States | $0.263B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.261B | 41.20 |
| Nuvectra (NVTR) | United States | $0.260B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.248B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.228B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.227B | 39.13 |
| Helius Medical Technologies (HSDT) | United States | $0.217B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.164B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.132B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.120B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.106B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.079B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.073B | 0.00 |
| EDAP TMS (EDAP) | France | $0.072B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.064B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.063B | 0.00 |
| Vermillion (VRML) | United States | $0.054B | 0.00 |
| Electromed (ELMD) | United States | $0.042B | 20.00 |
| OBALON THERPTCS (OBLN) | United States | $0.040B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.039B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.037B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.036B | 0.00 |
| ConforMIS (CFMS) | United States | $0.034B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.030B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.030B | 0.00 |
| PAVmed (PAVM) | United States | $0.026B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.024B | 0.00 |
| Dynatronics (DYNT) | United States | $0.023B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.020B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.020B | 0.00 |
| Neovasc (NVCN) | Canada | $0.018B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.015B | 72.00 |
| American Shared Hospital Services (AMS) | United States | $0.014B | 10.96 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.012B | 0.00 |
| Presbia (LENS) | Ireland | $0.009B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| Micron Solutions (MICR) | United States | $0.008B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.008B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.007B | 0.00 |
| Avinger (AVGR) | United States | $0.007B | 0.00 |
| InspireMD (NSPR) | Israel | $0.006B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.005B | 0.00 |
| Amedica (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
